{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:05:24Z","timestamp":1769745924350,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.diabres.2025.113057","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:17:23Z","timestamp":1765725443000},"page":"113057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effect of metformin on central arterial stiffness in individuals with type 2 diabetes mellitus: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"231","author":[{"given":"Anditri","family":"Weningtyas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Alvianoes Guterez","family":"Hose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Ramadhiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Saifur","family":"Rohman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dian","family":"Nugrahenny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achmad","family":"Rudijanto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10397","key":"10.1016\/j.diabres.2025.113057_b0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.diabres.2025.113057_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-022-13759-9","article-title":"Prevalence, awareness and control of type 2 diabetes mellitus and risk factors in Chinese elderly population","volume":"22","author":"Yan","year":"2022","journal-title":"BMC Public Health"},{"issue":"7","key":"10.1016\/j.diabres.2025.113057_b0015","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/HYPERTENSIONAHA.122.19256","article-title":"Hypertension, arterial stiffness, and diabetes: a prospective cohort Study","volume":"79","author":"Tian","year":"2022","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.diabres.2025.113057_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-023-35589-4","article-title":"Determinants of arterial stiffness in patients with type 2 diabetes mellitus: a cross sectional analysis","volume":"13","author":"Staef","year":"2023","journal-title":"Sci Rep"},{"issue":"S3","key":"10.1016\/j.diabres.2025.113057_b0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.15663","article-title":"Therapeutic profile in the treatment of type 2 diabetes","volume":"26","author":"Metformin","year":"2024","journal-title":"Diabetes, Obes Metab"},{"issue":"19","key":"10.1016\/j.diabres.2025.113057_b0030","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1111\/jcmm.17519","article-title":"Protective effects of metformin in various cardiovascular diseases: clinical evidence and AMPK-dependent mechanisms","volume":"26","author":"Bu","year":"2022","journal-title":"J Cell Mol Med"},{"issue":"8","key":"10.1016\/j.diabres.2025.113057_b0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/1753-0407.13405","article-title":"Effects of first-line antidiabetic drugs on the improvement of arterial stiffness: a Bayesian network meta-analysis","volume":"15","author":"Wang","year":"2023","journal-title":"J Diabetes"},{"key":"10.1016\/j.diabres.2025.113057_b0040","first-page":"6","article-title":"Effects of metformin on arterial elasticity and pro-inflammatory markers in black diabetes patients","volume":"29","author":"Rasakanya","year":"2024","journal-title":"Heal SA Gesondheid"},{"issue":"2","key":"10.1016\/j.diabres.2025.113057_b0045","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/HJH.0000000000001892","article-title":"Metformin use in type 2 diabetic patients is not associated with lower arterial stiffness: the Maastricht Study","volume":"37","author":"Driessen","year":"2019","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.diabres.2025.113057_b0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.14310\/horm.2002.1512","article-title":"Effect of vildagliptin on hsCRP and arterial stiffness in patients with type 2 diabetes mellitus","volume":"14","author":"Zografou","year":"2015","journal-title":"Hormones"},{"issue":"10","key":"10.1016\/j.diabres.2025.113057_b0055","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-0029-1202792","article-title":"Comparative study of low-dose pioglitazone or metformin treatment in ia pa nese diabetic patients with metabolic syndrome","volume":"117","author":"Kato","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2025.113057_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01183-5","article-title":"Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial","volume":"20","author":"Tuttolomondo","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.diabres.2025.113057_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-017-0646-z","article-title":"Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes","volume":"17","author":"Lambadiari","year":"2018","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.diabres.2025.113057_b0070","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/ehjcvp\/pvz078","article-title":"Combination of empagliflozin and linagliptin improves blood pressure and vascular function in type 2 diabetes","volume":"6","author":"Jung","year":"2020","journal-title":"Eur Hear J - Cardiovasc Pharmacother"},{"issue":"1","key":"10.1016\/j.diabres.2025.113057_b0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12933-017-0621-8","article-title":"Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study","volume":"16","author":"Solini","year":"2017","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.diabres.2025.113057_b0080","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/dom.12572","article-title":"Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes","volume":"17","author":"Chilton","year":"2015","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.diabres.2025.113057_b0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1479164111404257","article-title":"A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-\/- mouse model","volume":"8","author":"Gaspari","year":"2011","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.diabres.2025.113057_b0090","doi-asserted-by":"crossref","unstructured":"Tang L, Sun Q, Luo J, Peng S. Metformin hydrochloride improves hepatic glucolipid metabolism in diabetes progression through SIRT5-mediated ECHA desuccinylation. 2025;(2):1\u201311.","DOI":"10.1038\/s41598-025-92716-z"},{"key":"10.1016\/j.diabres.2025.113057_b0095","doi-asserted-by":"crossref","unstructured":"Cheng L, Deepak RNVK, Wang G, Liao Y, Wang Y, Lin JD, et al. Hepatic mitochondrial NAD + transporter SLC25A47 activates AMPK \u03b1 mediating lipid metabolism and tumorigenesis. 2023;(September 2022):1828\u201342.","DOI":"10.1097\/HEP.0000000000000314"},{"issue":"7","key":"10.1016\/j.diabres.2025.113057_b0100","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1096\/fj.13-245241","article-title":"SIRT5 is under the control of PGC-1\u03b1 and AMPK and is involved in regulation of mitochondrial energy metabolism","volume":"28","author":"Buler","year":"2014","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.diabres.2025.113057_b0105","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1002\/ctm2.172","article-title":"SIRT5 deficiency enhances the proliferative and therapeutic capacities of adipose-derived mesenchymal stem cells via metabolic switching","volume":"10","author":"Ou","year":"2020","journal-title":"Clin Transl Med"},{"issue":"1","key":"10.1016\/j.diabres.2025.113057_b0110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41467-022-28044-x","article-title":"The mitochondrial \u03b2-oxidation enzyme HADHA restrains hepatic glucagon response by promoting \u03b2-hydroxybutyrate production","volume":"13","author":"Pan","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.diabres.2025.113057_b0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s11033-022-07965-2","article-title":"HADHA alleviates hepatic steatosis and oxidative stress in NAFLD via inactivation of the MKK3\/MAPK pathway","volume":"50","author":"Ding","year":"2023","journal-title":"Mol Biol Rep"},{"issue":"3","key":"10.1016\/j.diabres.2025.113057_b0120","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/01.ATV.0000201938.78044.75","article-title":"Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells","volume":"26","author":"Isoda","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.diabres.2025.113057_b0125","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/db11-0416","article-title":"Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1\/AMPK\/ROS pathway and therapeutic effects of metformin","volume":"61","author":"Zheng","year":"2012","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.diabres.2025.113057_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062796","article-title":"Treating arterial ageing in patients with diabetes: from mechanisms to effective drugs","volume":"22","author":"Lunder","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.diabres.2025.113057_b0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/HJH.0b013e32834fa8b0","article-title":"Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity","volume":"30","author":"Van Bortel","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.diabres.2025.113057_b0140","unstructured":"Rasakanya TL, Osuch E, Makgatho S, Africa S, Rasakanya T. Effects of metformin on arterial elasticity and pro-inflammatory markers in black diabetes patients. 2012;6\u201311."},{"issue":"3","key":"10.1016\/j.diabres.2025.113057_b0145","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1871530315666150316124019","article-title":"Metformin and inflammation: its potential beyond glucose-lowering effect","volume":"15","author":"Saisho","year":"2015","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.diabres.2025.113057_b0150","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-023-01051-y","article-title":"Molecular mechanisms of action of metformin: latest advances and therapeutic implications PM particulate matter","author":"Zhu","year":"2023","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.diabres.2025.113057_b0155","article-title":"Metformin improves endothelial function and reduces blood pressure in diabetic spontaneously hypertensive rats independent from glycemia control","author":"Shishavan","year":"2017","journal-title":"Comparison to Vildagliptin"},{"key":"10.1016\/j.diabres.2025.113057_b0160","doi-asserted-by":"crossref","unstructured":"Hung CH, Chan SH, Chu PM, Lin HC. Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling. Oncotarget. 2016;7(10).","DOI":"10.18632\/oncotarget.7387"},{"issue":"19","key":"10.1016\/j.diabres.2025.113057_b0165","doi-asserted-by":"crossref","DOI":"10.7150\/thno.64706","article-title":"Metformin in cardiovascular diabetology\u00a0: a focused review of its impact on endothelial function","volume":"11","author":"Ding","year":"2021","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.diabres.2025.113057_b0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"Lamoia","year":"2021","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabres.2025.113057_b0175","doi-asserted-by":"crossref","unstructured":"Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertens (Dallas, Tex 1979) [Internet]. 2007 Jul;50(1):197\u2013203. 17485598.","DOI":"10.1161\/HYPERTENSIONAHA.107.089078"},{"issue":"15","key":"10.1016\/j.diabres.2025.113057_b0180","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/eurheartj\/ehq024","article-title":"Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis","volume":"31","author":"Vlachopoulos","year":"2010","journal-title":"Eur Heart J"},{"issue":"26","key":"10.1016\/j.diabres.2025.113057_b0185","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/eurheartj\/eht565","article-title":"Central blood pressure: current evidence and clinical importance","volume":"35","author":"McEniery","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diabres.2025.113057_b0190","doi-asserted-by":"crossref","unstructured":"Williams B, Lacy PS. Central haemodynamics and clinical outcomes: going beyond brachial blood pressure? [Internet]. Vol. 31, European heart journal. England; 2010. p. 1819\u201322. 20472919.","DOI":"10.1093\/eurheartj\/ehq125"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725010721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725010721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T14:21:49Z","timestamp":1769696509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725010721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S0168822725010721"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.113057","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of metformin on central arterial stiffness in individuals with type 2 diabetes mellitus: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.113057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113057"}}